{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:43:09Z","timestamp":1779183789356,"version":"3.51.4"},"reference-count":36,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It has been shown that mice with complete deficiency of all 4.1R protein isoforms (4.1-\/-) exhibit moderate hemolytic anemia, with abnormal erythrocyte morphology (spherocytosis) and decreased membrane stability. Here, we characterized the Gardos channel function in vitro and in vivo in erythrocytes of 4.1-\/- mice. Compared with wild-type, the Gardos channel of 4.1-\/- erythrocytes showed an increase in Vmax (9.75 \u00b1 1.06 vs 6.08 \u00b1 0.09 mM cell \u00d7 minute; P &amp;lt; .04) and a decrease in Km (1.01 \u00b1 0.06 vs 1.47 \u00b1 1.02 \u03bcM; P &amp;lt; .03), indicating an increased sensitivity to activation by intracellular calcium. In vivo function of the Gardos channel was assessed by the oral administration of clotrimazole, a well-characterized Gardos channel blocker. Clotrimazole treatment resulted in worsening of anemia and hemolysis, with decreased red cell survival and increased numbers of circulating hyperchromic spherocytes and microspherocytes. Clotrimazole induced similar changes in 4.2-\/- and band 3+\/- mice, indicating that these effects of the Gardos channel are shared in different models of murine spherocytosis. Thus, potassium and water loss through the Gardos channel may play an important protective role in compensating for the reduced surface-membrane area of hereditary spherocytosis (HS) erythrocytes and reducing hemolysis in erythrocytes with cytoskeletal impairments. (Blood. 2005;106:1454-1459)<\/jats:p>","DOI":"10.1182\/blood-2005-01-0368","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T03:09:26Z","timestamp":1114571366000},"page":"1454-1459","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":26,"title":["Evidence for a protective role of the Gardos channel against hemolysis in murine spherocytosis"],"prefix":"10.1182","volume":"106","author":[{"given":"Lucia","family":"De Franceschi","sequence":"first","affiliation":[{"name":"From the Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, Verona, Italy; Departments of Laboratory Medicine and Pathology, Children's Hospital Boston, Harvard Medical School, Boston, MA; The Jackson Laboratory, Bar Harbor, ME; Lawrence Berkeley National Laboratory, Berkeley, CA; and New York Blood Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Rivera","sequence":"additional","affiliation":[{"name":"From the Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, Verona, Italy; Departments of Laboratory Medicine and Pathology, Children's Hospital Boston, Harvard Medical School, Boston, MA; The Jackson Laboratory, Bar Harbor, ME; Lawrence Berkeley National Laboratory, Berkeley, CA; and New York Blood Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Fleming","sequence":"additional","affiliation":[{"name":"From the Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, Verona, Italy; Departments of Laboratory Medicine and Pathology, Children's Hospital Boston, Harvard Medical School, Boston, MA; The Jackson Laboratory, Bar Harbor, ME; Lawrence Berkeley National Laboratory, Berkeley, CA; and New York Blood Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Honczarenko","sequence":"additional","affiliation":[{"name":"From the Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, Verona, Italy; Departments of Laboratory Medicine and Pathology, Children's Hospital Boston, Harvard Medical School, Boston, MA; The Jackson Laboratory, Bar Harbor, ME; Lawrence Berkeley National Laboratory, Berkeley, CA; and New York Blood Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luanne L.","family":"Peters","sequence":"additional","affiliation":[{"name":"From the Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, Verona, Italy; Departments of Laboratory Medicine and Pathology, Children's Hospital Boston, Harvard Medical School, Boston, MA; The Jackson Laboratory, Bar Harbor, ME; Lawrence Berkeley National Laboratory, Berkeley, CA; and New York Blood Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Gascard","sequence":"additional","affiliation":[{"name":"From the Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, Verona, Italy; Departments of Laboratory Medicine and Pathology, Children's Hospital Boston, Harvard Medical School, Boston, MA; The Jackson Laboratory, Bar Harbor, ME; Lawrence Berkeley National Laboratory, Berkeley, CA; and New York Blood Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narla","family":"Mohandas","sequence":"additional","affiliation":[{"name":"From the Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, Verona, Italy; Departments of Laboratory Medicine and Pathology, Children's Hospital Boston, Harvard Medical School, Boston, MA; The Jackson Laboratory, Bar Harbor, ME; Lawrence Berkeley National Laboratory, Berkeley, CA; and New York Blood Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Brugnara","sequence":"additional","affiliation":[{"name":"From the Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, Verona, Italy; Departments of Laboratory Medicine and Pathology, Children's Hospital Boston, Harvard Medical School, Boston, MA; The Jackson Laboratory, Bar Harbor, ME; Lawrence Berkeley National Laboratory, Berkeley, CA; and New York Blood Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021219463735700_REF1","doi-asserted-by":"crossref","unstructured":"Brugnara C. Erythrocyte membrane transport physiology. Curr Opin Hematol.1997;4: 122-127.","DOI":"10.1097\/00062752-199704020-00008"},{"key":"2020021219463735700_","unstructured":"Brugnara C. Red cell membrane in sickle cell disease. In: Forget B, Higgs D, Nagel R, Steinberg M, eds. Disorders of Hemoglobin. New York, NY: Cambridge University Press; 2001: 550-576."},{"key":"2020021219463735700_","doi-asserted-by":"crossref","unstructured":"Olivieri O, Bonollo M, Friso S, Girelli D, Corrocher R, Vettore L. Activation of K+\/Cl- cotransport in human erythrocytes exposed to oxidative agents. Biochim Biophys Acta.1993;1176: 37-42.","DOI":"10.1016\/0167-4889(93)90174-N"},{"key":"2020021219463735700_REF4","doi-asserted-by":"crossref","unstructured":"Olivieri O, De Franceschi L, Capellini MD, Girelli D, Corrocher R, Brugnara C. Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood.1994;84: 315-320.","DOI":"10.1182\/blood.V84.1.315.315"},{"key":"2020021219463735700_REF5","doi-asserted-by":"crossref","unstructured":"Hoffman JF, Joiner W, Nehrke K, Potapova O, Foye K, Wickrema A. The hSK4 (KCNN4) isoform is the Ca2+-activated K+ channel (Gardos channel) in human red cells. Proc Natl Acad Sci U S A.2003;100: 7366-7371.","DOI":"10.1073\/pnas.1232342100"},{"key":"2020021219463735700_REF6","doi-asserted-by":"crossref","unstructured":"Brugnara C. Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration. J Pediatr Hematol\/Oncol.2003;25: 927-933.","DOI":"10.1097\/00043426-200312000-00004"},{"key":"2020021219463735700_REF7","doi-asserted-by":"crossref","unstructured":"Bertles JF. Sodium transport across the surface membrane of red blood cells in hereditary spherocytosis. J Clin Invest.1957;36: 816-823.","DOI":"10.1172\/JCI103487"},{"key":"2020021219463735700_REF8","doi-asserted-by":"crossref","unstructured":"Jacob HS, Jandl JH. Increased cell membrane permeability in the pathogenesis of hereditary spherocytosis. J Clin Invest.1964;43: 1704-1720.","DOI":"10.1172\/JCI105046"},{"key":"2020021219463735700_","doi-asserted-by":"crossref","unstructured":"Wiley J. Red cell survival studies in hereditary spherocytosis. J Clin Invest.1970;49: 666-672.","DOI":"10.1172\/JCI106278"},{"key":"2020021219463735700_","doi-asserted-by":"crossref","unstructured":"Zipursky A, Israels LG. Significance of erythrocyte sodium flux in the pathophysiology and genetic expression of hereditary spherocytosis. Pediatr Res.1971;5: 614-617.","DOI":"10.1203\/00006450-197111000-00005"},{"key":"2020021219463735700_","doi-asserted-by":"crossref","unstructured":"Wiley JS. Coordinated increase of sodium leak and sodium pump in hereditary spherocytosis. Br J Haematol.1972;22: 529-542.","DOI":"10.1111\/j.1365-2141.1972.tb05700.x"},{"key":"2020021219463735700_REF12","doi-asserted-by":"crossref","unstructured":"Mayman D, Zipursky A. Hereditary spherocytosis: the metabolism of erythrocytes in the peripheral blood and in the splenic pulp. Br J Haematol.1974;27: 201-217.","DOI":"10.1111\/j.1365-2141.1974.tb06787.x"},{"key":"2020021219463735700_REF13","unstructured":"Lux SE, Palek J. Disorders of the red cell membrane. In: Handin RJ, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. Philadelphia, PA: Lippincott-Raven; 1995: 1701-1818."},{"key":"2020021219463735700_REF14","doi-asserted-by":"crossref","unstructured":"De Franceschi L, Olivieri O, Miraglia del Giudice E, et al. Membrane cation and anion transport activities in erythrocytes of hereditary spherocytosis: effects of different membrane protein defects. Am J Hematol.1997;55: 121-128.","DOI":"10.1002\/(SICI)1096-8652(199707)55:3<121::AID-AJH1>3.0.CO;2-U"},{"key":"2020021219463735700_REF15","doi-asserted-by":"crossref","unstructured":"Cynober T, Mohandas N, Tchernia G. Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med.1996;128: 259-269.","DOI":"10.1016\/S0022-2143(96)90027-X"},{"key":"2020021219463735700_REF16","doi-asserted-by":"crossref","unstructured":"Joiner CH, Franco RS, Jiang M, Franco MS, Barker JE, Lux SE. Increased cation permeability in mutant mouse red blood cells with defective membrane skeletons. Blood.1995;86: 4307-4314.","DOI":"10.1182\/blood.V86.11.4307.bloodjournal86114307"},{"key":"2020021219463735700_REF17","doi-asserted-by":"crossref","unstructured":"Peters LL, Shivdasani RA, Liu SC, et al. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell.1996;86: 917-927.","DOI":"10.1016\/S0092-8674(00)80167-1"},{"key":"2020021219463735700_REF18","doi-asserted-by":"crossref","unstructured":"Gilligan DM, Lozovatsky L, Gwynn B, Brugnara C, Mohandas N, Peters LL. Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. Proc Natl Acad Sci U S A.1999;96: 10717-10722.","DOI":"10.1073\/pnas.96.19.10717"},{"key":"2020021219463735700_REF19","doi-asserted-by":"crossref","unstructured":"Peters LL, Jindel HK, Gwynn B, et al. Mild spherocytosis and altered red cell ion transport in protein 4.2-null mice. J Clin Invest.1999;103: 1527-1537.","DOI":"10.1172\/JCI5766"},{"key":"2020021219463735700_REF20","doi-asserted-by":"crossref","unstructured":"Shi ZT, Afzal V, Coller B, et al. Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities. J Clin Invest.1999;103: 331-340.","DOI":"10.1172\/JCI3858"},{"key":"2020021219463735700_REF21","doi-asserted-by":"crossref","unstructured":"De Franceschi L, Fumagalli L, Olivieri O, Corrocher R, Lowell CA, Berton G. Deficiency of src family kinases Fgr and Hck results in activation of erythrocyte K\/Cl cotransport. J Clin Invest.1997;99: 220-227.","DOI":"10.1172\/JCI119150"},{"key":"2020021219463735700_REF22","doi-asserted-by":"crossref","unstructured":"Wolff D, Cecchi X, Spalvins A, Canessa M. Charybdotoxin blocks with high affinity the Ca-activated K+ channel of Hb A and Hb S red cells: individual differences in the number of channels. J Membr Biol.1988;106: 243-252.","DOI":"10.1007\/BF01872162"},{"key":"2020021219463735700_REF23","doi-asserted-by":"crossref","unstructured":"Rivera A, Rotter MA, Brugnara C. Endothelins activate Ca(2+)-gated K(+) channels via endothelin B receptors in CD-1 mouse erythrocytes. Am J Physiol.1999;277: C746-C754.","DOI":"10.1152\/ajpcell.1999.277.4.C746"},{"key":"2020021219463735700_REF24","unstructured":"Brugnara C, Armsby CC, Sakamoto M, Rifai N, Alper SL, Platt O. Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activity. J Pharmacol Exp Therapeut.1995;273: 266-272."},{"key":"2020021219463735700_REF25","doi-asserted-by":"crossref","unstructured":"de Jong K, Emerson RK, Butler J, Bastacky J, Mohandas N, Kuypers FA. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia. Blood.2001;98: 1577-1584.","DOI":"10.1182\/blood.V98.5.1577"},{"key":"2020021219463735700_REF26","doi-asserted-by":"crossref","unstructured":"Friedman JS, Rebel VI, Derby R, et al. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med.2001;193: 925-934.","DOI":"10.1084\/jem.193.8.925"},{"key":"2020021219463735700_REF27","doi-asserted-by":"crossref","unstructured":"De Franceschi L, Saadane N, Trudel M, Alper SL, Brugnara C, Beuzard Y. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice: a model for therapy of sickle cell disease. J Clin Invest.1994;93: 1670-1676.","DOI":"10.1172\/JCI117149"},{"key":"2020021219463735700_REF28","doi-asserted-by":"crossref","unstructured":"Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery GS. Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs.1975;9: 424-447.","DOI":"10.2165\/00003495-197509060-00003"},{"key":"2020021219463735700_REF29","doi-asserted-by":"crossref","unstructured":"Matsuura Y, Kotani E, Iio T, et al. Structure-activity relationships in the induction of hepatic microsomal cytochrome P450 by clotrimazole and itsstructurally related compounds in rats. Biochem Pharmacol.1991;41: 1949-1956.","DOI":"10.1016\/0006-2952(91)90135-R"},{"key":"2020021219463735700_REF30","doi-asserted-by":"crossref","unstructured":"Stocker JW, De Franceschi L, McNaughton-Smith GA, Corrocher R, Beuzard Y, Brugnara C. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood.2003;101: 2412-2418.","DOI":"10.1182\/blood-2002-05-1433"},{"key":"2020021219463735700_REF31","unstructured":"Stocker JW, De Franceschi L, McNaughton-Smith G, Brugnara C. A novel Gardos channel inhibitor, ICA-17043, prevents red blood cell dehydration in vitro and in a mouse model (SAD) of sickle cell disease [abstract]. Blood.2000;96: 486."},{"key":"2020021219463735700_REF32","doi-asserted-by":"crossref","unstructured":"Halperin JA, Brugnara C, Nicholson-Weller A. Ca2+-activated K+ efflux limits complement-mediated lysis of human erythrocytes. J Clin Invest.1989;83: 1466-1471.","DOI":"10.1172\/JCI114039"},{"key":"2020021219463735700_REF33","doi-asserted-by":"crossref","unstructured":"Halperin JA, Nicholson-Weller A, Brugnara C, Tosteson DC. Complement induces a transient increase in membrane permeability in unlysed erythrocytes. J Clin Invest.1988;82: 594-600.","DOI":"10.1172\/JCI113637"},{"key":"2020021219463735700_REF34","doi-asserted-by":"crossref","unstructured":"Ronquist G, Rudolphi O, Engstrom I, Walden-strom A. Familial phosphofructokinase deficiency is associated with a disturbed calcium homeostasis in erythrocytes. J Intern Med.2001;249: 85-95.","DOI":"10.1046\/j.1365-2796.2001.00780.x"},{"key":"2020021219463735700_REF35","doi-asserted-by":"crossref","unstructured":"Kaestner L, Tabellion W, Lipp P, Bernhardt I. Prostaglandin E(2-) activates channel-mediated calcium entry in human erythrocytes: an indicator for a blood clot formation supporting process. Thromb Haemost.2004;92: 1269-1272.","DOI":"10.1160\/TH04-06-0338"},{"key":"2020021219463735700_REF36","doi-asserted-by":"crossref","unstructured":"Gibson JS, Muzyamba MC. Modulation of Gardos channel activity by oxidants and oxygen tension: effects of 1-chloro-2,4-dinitrobenzene and phenazine methosulphate. Bioelectrochemistry.2004;62: 147-152.","DOI":"10.1016\/j.bioelechem.2003.07.008"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/4\/1454\/1712765\/zh801605001454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/4\/1454\/1712765\/zh801605001454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T02:43:25Z","timestamp":1586227405000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/4\/1454\/21577\/Evidence-for-a-protective-role-of-the-Gardos"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,15]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-01-0368","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,15]]}}}